RxDoctor Payments Data

Wei Ding

Hematology · Stanford, CANPI 1265454201

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Octapharma USA, Inc. accounts for 68.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $4,650 and has fallen 99.8% since, to $11 in 2022. That places this record below the midpoint for hematology clinicians in CA, where the typical reported total is $4,615.

$6,611in general payments, 2019–2025

Across 8 payments — averaging $826.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Octapharma USA, Inc.$5K
  • Beigene USA, Inc.$2K
  • Verastem, Inc.$94
  • Merck$11
$3,730,299in research payments, 2019–2025

Across 144 payments — averaging $25,905 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1.5M
  • AstraZeneca$1.3M
  • Beigene, Ltd.$483K
  • Beigene AUS Pty Ltd$301K
  • Octapharma USA, Inc.$77K
  • AbbVie$52K

What the payments were for

  • Consulting fees$1,95029%
  • Speaking & faculty fees$3,50053%
  • Travel & lodging$1,02716%
  • Food & beverage$1232%
  • Education$110%

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Octapharma USA, Inc.4$4,555
Beigene USA, Inc.2$1,950
Verastem, Inc.1$94
Merck1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,611 in reported general payments places this provider in the 50th percentile of 178 hematology providers in California.

See all hematology providers in California →

Other hematology in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →